February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- What They Are Saying: Senate Republicans’ Legislation Delivers for American Workers, Businesses
- Republicans are Providing Tax Relief to Working Families and Main Street
- Republicans are Powering the Economy Through Pro-Growth Tax Policy
- Republicans’ Legislation Achieves Record Savings
- Crapo Statement on JCT Analysis of Tax Title